Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > The charts are saying that we have---

<< Previous

Bullboard Posts

Next >>

Comment by menoalittleon Nov 16, 2024 11:50am

141 Views

Post# 36316469

RE:The charts are saying that we have---

>> One more day (monday) of staying flat

Maybe... or, maybe not.

And presumably, you mean to refer to the BTD application (for TLD-1433, aka Ruvidar)... which also, may or may not have news as early as next Tuesday. Frankly, I'd sooner expect other news (their quarterly financials, for example) before any BTD related news, simply because it seems to be a more typical pattern that they release news in. (Smaller news leading up to bigger news.)

But, what do I know.

<< Previous

Bullboard Posts

Next >>

Investor’s corner: Solving chronic pain in dogs – A significant market opportunity